# FOLICOLOR TRIAL: Following Therapy Response Through Liquid Biopsy in Metatstatic Colorectal Cancer Patients

Source: https://onco.cc/trials/nct07558083/  
OnCo record `nct07558083` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in colorectal cancer, run by University Hospital, Antwerp, now recruiting.

## Summary

FOLICOLOR TRIAL: Following Therapy Response Through Liquid Biopsy in Metatstatic Colorectal Cancer Patients is a phase 3, randomised interventional study registered as NCT07558083 by University Hospital, Antwerp, with a registry enrolment figure of 150 participants, started 2021-08-16 and due to reach its primary completion in 2029-12. Interventions recorded: Evaluation therapy through Liquid Biopsy. Conditions listed: Advanced Colorectal Cancer. Primary outcome: Time to Deterioration (TTD) in Quality of Life (QoL). Colorectal eligibility wording from the registry: "* Histologically or cytologically confirmed adenocarcinoma of the colon or rectum in subjects with unresectable metastatic (M1) disease". Sites: Belgium. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: FOLICOLOR
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT07558083
- Phase: 3
- Setting: FOLICOLOR TRIAL: Following Therapy Response Through Liquid Biopsy in Metatstatic Colorectal Cancer Patients
- Sponsor: University Hospital, Antwerp
- Enrolled: 150

## Sources

- ClinicalTrials.gov NCT07558083: https://clinicaltrials.gov/study/NCT07558083

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07558083.json